Mideran en es it fr

Mideran Brand names, Mideran Analogs

Mideran Brand Names Mixture

  • Tritec (ranitidine bismuth citrate salt)

Mideran Chemical_Formula


Mideran RX_link


Mideran fda sheet

Mideran FDA

Mideran msds (material safety sheet)

Mideran MSDS

Mideran Synthesis Reference

B. J. Price et al., U.S. Pat. 4,128,658 (1978)

Mideran Molecular Weight

314.405 g/mol

Mideran Melting Point

69-70 oC

Mideran H2O Solubility

24.7 mg/mL

Mideran State


Mideran LogP


Mideran Dosage Forms

Capsule; Liquid; Solution; Tablet; Syrup

Mideran Indication

Used in the treatment of peptic ulcer disease (PUD), dyspepsia, stress ulcer prophylaxis, and gastroesophageal reflux disease (GERD).

Mideran Pharmacology

Ranitidine is a histamine H2-receptor antagonist similar to cimetidine and famotidine. An H2-receptor antagonist, often shortened to H2 antagonist, is a drug used to block the action of histamine on parietal cells in the stomach, decreasing acid production by these cells. These drugs are used in the treatment of dyspepsia, however their use has waned since the advent of the more effective proton pump inhibitors. Like the H1-antihistamines, the H2 antagonists are inverse agonists rather than true receptor antagonists.

Mideran Absorption

Approximately 50% bioavailability orally.

Mideran side effects and Toxicity

LD50=77mg/kg (orally in mice). Symptoms of overdose include muscular tremors, vomiting, and rapid respiration.

Mideran Patient Information


Phenylketonurics: ZANTAC 25 EFFERdose Tablets contain phenylalanine 2.81 mg per 25 mg of ranitidine. ZANTAC 150 EFFERdose Tablets
contain phenylalanine 16.84 mg per 150 mg of ranitidine. ZANTAC EFFERdose Tablets should not be chewed, swallowed whole, or dissolved
on the tongue.

Mideran Organisms Affected

Humans and other mammals